Minimally-invasive surgery

joimax® Announces Strategic Partnership With NAMSA

Retrieved on: 
Wednesday, July 21, 2021

joimax , the German-based market leader in technologies and training methods for full-endoscopic and minimally-invasive spinal surgery, is pleased to announce a new strategic partnership with NAMSA, the only full continuum Contract Research Organization (CRO) in the world focused exclusively on medical devices.

Key Points: 
  • joimax , the German-based market leader in technologies and training methods for full-endoscopic and minimally-invasive spinal surgery, is pleased to announce a new strategic partnership with NAMSA, the only full continuum Contract Research Organization (CRO) in the world focused exclusively on medical devices.
  • We are excited for NAMSA to serve as an exclusive partner to help patients access joimax endoscopic technologies, stated joimax General Manager Maximilian Ries.
  • Founded in Karlsruhe, Germany in 2001, joimax is the leading developer and marketer of complete systems for full-endoscopic and minimally-invasive spinal surgery.
  • Helping medical device Sponsors improve healthcare since 1967, NAMSA is the worlds only 100% medical device-focused, full continuum Contract Research Organization (CRO).

GPS-Like Robot Proves 'Groundbreaking' in Spinal Surgery

Retrieved on: 
Wednesday, July 21, 2021

The robot proved quicker and more precise than any experienced surgeon performing a standard spinal fusion.

Key Points: 
  • The robot proved quicker and more precise than any experienced surgeon performing a standard spinal fusion.
  • The patient was able to be discharged home same day with almost no pain following surgery, assisted with continuous pain infusion for up to 3 days," said Dr. Kadimcherla, a renowned spinal surgeon noted for his expertise in endoscopic and minimally invasive spine surgery.
  • He and his colleague, Kaixuan Liu, MD , performed the robotic operation at their center's Advanced Spine and Outpatient Surgery facility.
  • Atlantic Spine Center is a nationally recognized leader for endoscopic spine surgery with several locations in NJ and NYC.

Largest U.S. Healthcare Claims and Utilization Analysis for BPH Procedures Reveals Lowest Overall Complication Rates and Consistent Durability after Treatment with Minimally Invasive UroLift System

Retrieved on: 
Friday, July 9, 2021

WAYNE, Pa., July 09, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) today announced that the largest U.S. healthcare claims and utilization analysis for benign prostatic hyperplasia (BPH) surgical and minimally invasive procedures reveals that overall complication rates are lowest after treatment with the UroLift System.

Key Points: 
  • WAYNE, Pa., July 09, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) today announced that the largest U.S. healthcare claims and utilization analysis for benign prostatic hyperplasia (BPH) surgical and minimally invasive procedures reveals that overall complication rates are lowest after treatment with the UroLift System.
  • Existing research in the area of surgical or minimally invasive procedures for BPH is sparse, said Daniel Rukstalis, M.D.
  • Taken together, this large-scale analysis of U.S. real-world claims data reveals that overall rates of complications are lowest after treatment with the UroLift System and that surgical retreatment rates are similar among the UroLift System, TURP and GreenLight procedures.
  • The UroLift System is a minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH).

Teleflex Announces Real-World Clinical Data Presentations of the UroLift® System at the 36th Annual European Association of Urology Congress

Retrieved on: 
Tuesday, July 6, 2021

The UroLift System is a minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH).

Key Points: 
  • The UroLift System is a minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH).
  • The UroLift System is the only leading BPH procedure shown to not cause new onset, sustained erectile or ejaculatory dysfunction.
  • The Prostatic Urethral Lift procedure (using the UroLift System) is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines.
  • Teleflex is the home of Arrow, Deknatel, LMA, Pilling, Rusch, UroLift and Wecktrusted brands united by a common sense of purpose.

PROCEPT® BioRobotics Announces $85M Financing Led by Fidelity Management & Research Company LLC

Retrieved on: 
Wednesday, June 30, 2021

REDWOOD CITY, Calif., June 30, 2021 /PRNewswire/ --PROCEPT BioRobotics Corporation ("PROCEPT" or "PROCEPT BioRobotics"), a surgical robotics company developing intelligent solutions to transform the field of urology, today announced an $85 million Series G financing round led by Fidelity Management & Research Company LLC.

Key Points: 
  • REDWOOD CITY, Calif., June 30, 2021 /PRNewswire/ --PROCEPT BioRobotics Corporation ("PROCEPT" or "PROCEPT BioRobotics"), a surgical robotics company developing intelligent solutions to transform the field of urology, today announced an $85 million Series G financing round led by Fidelity Management & Research Company LLC.
  • The system delivers Aquablation therapy, the first and only image-guided robotic therapy for the treatment of benign prostatic hyperplasia (BPH).
  • "We would like to welcome both Fidelity Management & Research Company LLC and T. Rowe Price Associates as shareholders to our company and thank our existing investors for their continued support.
  • PROCEPT BioRobotics is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology.

joimax® Launches New Generation of Shrill® Shaver Drill System

Retrieved on: 
Thursday, June 24, 2021

German-based joimax, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce the global launch of its new generation Shrill, the Shaver Drill System.

Key Points: 
  • German-based joimax, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce the global launch of its new generation Shrill, the Shaver Drill System.
  • Developed for the removal of soft tissue and bone, the joimax Shrill system is also highly effective in treating stenosis, a degenerative spine condition.
  • View the full release here: https://www.businesswire.com/news/home/20210624005838/en/
    joimax Launches New Generation of Shrill Shaver Drill System.
  • The Shrill system is compatible with the angulated Shrill Deflector Shaver Blades and a whole range of blades provided for all spinal applications.

Prime Foot & Ankle Specialists is now offering minimally invasive bunion surgery, hammer toe surgery from the Berkley Mi & Royal Oak Mi podiatrist offices.

Retrieved on: 
Tuesday, June 1, 2021

BERKLEY, Mich., June 1, 2021 /PRNewswire-PRWeb/ -- Prime Foot & Ankle Specialists are now offering minimally invasive bunion surgery , minimally invasive hammer toe surgery & minimally invasive foot surgery from the Berkley Mi podiatrist & Royal Oak Mi podiatrist offices.

Key Points: 
  • BERKLEY, Mich., June 1, 2021 /PRNewswire-PRWeb/ -- Prime Foot & Ankle Specialists are now offering minimally invasive bunion surgery , minimally invasive hammer toe surgery & minimally invasive foot surgery from the Berkley Mi podiatrist & Royal Oak Mi podiatrist offices.
  • Prime Foot & Ankle Specialists strive to provide modern podiatrist and foot doctor care to their patients through minimally invasive surgery office visits, telehealth, and home care options.
  • There are many advantages to minimally invasive bunion surgery, minimally invasive hammer toe surgery and minimally invasive foot surgery.
  • Minimally invasive bunion surgery, minimally invasive hammer toe surgery and minimally invasive foot surgery is just another way to accomplish better patient care.

Olympus Acquires Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth

Retrieved on: 
Friday, May 28, 2021
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210527005341/en/
    iTind is the newest addition to the portfolio of Olympus, a market leader in devices for BPH treatment.
  • (Graphic: Business Wire)
    Medi-Tate is a medical device manufacturer engaged in the research and development, production, and sale of devices for the minimally invasive treatment of BPH.
  • We are pleased to be joining Olympus, which shares our vision of making iTind the global standard for BPH treatment.
  • Medi-Tate is an Israeli medical device company dedicated to improving mens healthcare and quality of life via effective, non-surgical solutions for Benign Prostatic Hyperplasia (BPH).

EQS-News: Medacta Announces First U.S. Surgery with the New M.U.S.T. LT System in Minimally Invasive Spine Surgery

Retrieved on: 
Wednesday, April 28, 2021

LT System in Minimally Invasive Spine Surgery\nCASTEL SAN PIETRO, 28 April 2021 - Medacta announced today the first surgery utilizing its M.U.S.T.

Key Points: 
  • LT System in Minimally Invasive Spine Surgery\nCASTEL SAN PIETRO, 28 April 2021 - Medacta announced today the first surgery utilizing its M.U.S.T.
  • LT (Long Tab Screw System) is the new minimally invasive solution for posterior spine fixation in the percutaneous approach.
  • L.T.
  • LT system, Medacta continues to expand its fast-growing spine portfolio, delivering innovative solutions to surgeons for the benefit of their patients.\nFor more information on Medacta spine surgery solutions, please visit spine.medacta.com .\n'

Viseon Announces First Clinical Use of The Next Generation MaxView™ System for Minimally Invasive Oblique Lateral Lumbar Interbody Fusion

Retrieved on: 
Tuesday, April 13, 2021

b'Viseon Inc., a leader in visualization technology for minimally invasive spine surgery, announces the first clinical use of the next generation of the MaxView\xe2\x84\xa2 System for Oblique Lateral Interbody Fusion (OLIF\xe2\x84\xa2).

Key Points: 
  • b'Viseon Inc., a leader in visualization technology for minimally invasive spine surgery, announces the first clinical use of the next generation of the MaxView\xe2\x84\xa2 System for Oblique Lateral Interbody Fusion (OLIF\xe2\x84\xa2).
  • Viseon MaxView System provides the surgeon with high definition, intraoperative visualization of the surgical field on a head\xe2\x80\x99s up monitor display that is unobstructed by surgeon hands or instruments.
  • Center in Melbourne, FL, is the first surgeon to use the next generation MaxView System for OLIF\xe2\x84\xa2.
  • With the current trend moving toward more minimally invasive procedures, the next generation of surgeons need to be proficient in minimally invasive spine procedures.